JAK/TYK2
Dr. Janet Pope interviews Dr. Tom Appleton and Dr. Peter Nash about several osteoarthritis and psoriatic arthritis studies presented at the 2020 ACR annual meeting.
Dr. Jeffrey Curtis examines abstracts #1997 and #0452 presented at the ACR 2020 annual meeting.
Dr. Ruderman discusses a new pathway - the use of deucravacitinib - for the treatment of psoriatic arthritis (abstracts L03) at the ACR 2020 annual meeting.
Dr. Antoni Chan discusses abstracts #0369 and #0886 presented at the 2020 ACR annual meeting.
Chicago-based Dr. Eric Ruderman discussed the shifting treatment paradigms in psoriatic arthritis by reviewing abstracts #0504 and #2026 at ACR 2020.
OHSU rheumatologist Dr. Kevin Winthrop in Portland looks at two posters -- abstracts #0215 and #0229 presented Friday at ACR 2020.
Dr. Robert Chao discusses abstracts #0375 and #0381 as presented Friday at the ACR 2020 annual meeting.
San Francisco-based rheumatologist Dr. Lianne Gensler examines a wide range of spondyloarthritis topics at ACR 2020, including how to join up with others interested in spondyloarthritis; enthesitis; the utility of MRI for the diagnosis for axSpA; novel treatments; and the impact of drugs on disease modification.
Dr. Vibeke Strand discusses opening day at ACR 2020, sessions she's looking forward, and provides a sneak peek into The Great Debate.
Dr. Eric Ruderman, Chicago, IL., provides his perspective on ACR 2020 coverage of axial involvement in Psoriatic Arthritis. During his remarks, he discusses ACR abstracts #0344, #1372, #2025 and #0505.